Alex P. Michael

Alex P. Michael

Auto-generated profile, based on publicly available information

Alex P. Michael


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2015 in Journal of Neurotrauma
Verified
Journal Article
Closed access
AMAlex P. Michael
Alex P. Michael
JSJeffrey Stout
Jeffrey Stout
PRP. Tyler Roskos
P. Tyler Roskos
JBJacob Bolzenius
Jacob Bolzenius
JGJeffrey Gfeller
Jeffrey Gfeller
RBRichard Bucholz
Richard Bucholz
Military service members frequently sustain traumatic brain injuries (TBI) while on active duty, a majority of which are related to explosive blasts and are mild in severity. Studies evaluating the cortical gray matter in persons with injuries of this nature remain scarce. The purpose of this study was to assess cortical thickness in a sample of military veterans with chronic blast-related TBI. Thirty-eight veterans with mild TBI and 17 veterans with moderate TBI were compared with 58 demographically matched healthy civilians. All veterans with TBI sustained injuries related to a blast and were between 5 and 120 months post-injury ( M = 62.08). Measures of post-traumatic stress disorder (PTSD) and depression were administered, along with a battery of neuropsychological tests to assess cognition. The Freesurfer software package was used to calculate cortical thickness of the participants. Results demonstrated significant clusters of cortical thinning in the right hemispheric insula and inferior portions of the temporal and frontal lobe in both mild and moderate TBI participants. The TBI sample from this study demonstrated a high incidence of comorbid PTSD and depression symptoms, which is consistent with the previous literature. Cortical thickness values correlated with measures of PTSD, depression, and post-concussive symptoms. This study provides evidence of cortical thinning in the context of chronic blast-related mild and moderate TBI in military veterans who have comorbid psychiatric symptoms. Our findings provide important insight into the natural progression of long-term cortical change in this population and may have implications for future clinical evaluation and treatment.

14 January 2019 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
AMAlex P. Michael
Alex P. Michael
VWVictoria L. Watson
Victoria L. Watson
DRDaniel Ryan
Daniel Ryan
KDKristin R. Delfino
Kristin R. Delfino
SBSimon V. Bekker
Simon V. Bekker
JCJeffrey W. Cozzens
Jeffrey W. Cozzens

1 August 2019 in Journal of Neurosurgery: Spine
Verified
Journal Article
Closed access
PDF file
AMAlex P. Michael
Alex P. Michael
MWMatthew W. Weber
Matthew W. Weber
KDKristin R. Delfino
Kristin R. Delfino
VGVenkatanarayanan Ganapathy
Venkatanarayanan Ganapathy
OBJECTIVE: While long-term studies have evaluated adjacent-segment disease (ASD) following posterior lumbar spine arthrodesis, no such studies have assessed the incidence and prevalence of ASD following axial lumbar interbody fusion (AxiaLIF). The aim of this study was to estimate the incidence of ASD following AxiaLIF.METHODS: The authors retrospectively reviewed the medical records of 149 patients who underwent two-level index AxiaLIF and had at least 2 years of radiographic and clinical follow-up. ASD and pre- and postoperative lumbar lordosis were evaluated in each patient. ASD was defined as both radiographic and clinically significant disease at a level adjacent to a previous fusion requiring surgical intervention. The mean duration of follow-up was 6.01 years.RESULTS: Twenty (13.4%) of the 149 patients developed ASD during the data collection period. Kaplan-Meier analysis predicted a disease-free ASD survival rate of 95.3% (95% CI 90.4%–97.7%) at 2 years and 89.1% (95% CI 82.8%–93.2%) at 5 years for two-level fusion. A laminectomy adjacent to a fusion site was associated with 5.1 times the relative risk of developing ASD. Furthermore, the ASD group had significantly greater loss of lordosis than the no-ASD group (p = 0.033).CONCLUSIONS: Following two-level AxiaLIF, the rate of symptomatic ASD warranting either decompression or arthrodesis was found to be 4.7% at 2 years and 10.9% at 5 years. Adjacent-segment decompression and postoperative loss of lumbar lordosis predicted future development of ASD. To the authors’ knowledge, this is the largest reported cohort of patients to undergo two-level AxiaLIF in the United States.

17 January 2020 in Brain Sciences
Verified
Journal Article
Open access
PDF file
RKRICHARD E. KAST
RICHARD E. KAST
AMAlex P. Michael
Alex P. Michael
Iacopo SardiIacopo Sardi
Iacopo Sardi
TBTerry C. Burns
Terry C. Burns
THTim Heiland
Tim Heiland
MHMarc-Eric Halatsch
Marc-Eric Halatsch
Prognosis for diffuse intrinsic pontine glioma (DIPG) and generally for diffuse midline gliomas (DMG) has only marginally improved over the last ~40 years despite dozens of chemotherapy and other therapeutic trials. The prognosis remains invariably fatal. We present here the rationale for a planned study of adding 5-aminolevulinic acid (5-ALA) to the current irradiation of DIPG or DMG: the 5aai regimen. In a series of recent papers, oral 5-ALA was shown to enhance standard therapeutic ionizing irradiation. 5-ALA is currently used in glioblastoma surgery to enable demarcation of overt tumor margins by virtue of selective uptake of 5-ALA by neoplastic cells and selective conversion to protoporphyrin IX (PpIX), which fluoresces after excitation by 410 nm (blue) light. 5-ALA is also useful in treating glioblastomas by virtue of PpIX’s transfer of energy to O2 molecules, producing a singlet oxygen that in turn oxidizes intracellular DNA, lipids, and proteins, resulting in selective malignant cell cytotoxicity. This is called photodynamic treatment (PDT). Shallow penetration of light required for PpIX excitation and resultant energy transfer to O2 and cytotoxicity results in the inaccessibility of central structures like the pons or thalamus to sufficient light. The recent demonstration that keV and MeV photons can also excite PpIX and generate singlet O2 allows for reconsideration of 5-ALA PDT for treating DMG and DIPG. 5-ALA has an eminently benign side effect profile in adults and children. A pilot study in DIPG/DMG of slow uptitration of 5-ALA prior to each standard irradiation session—the 5aai regimen—is warranted.

25 April 2017 in Neurology
Verified
Journal Article
Closed access
PDF file
AMAlex P. Michael
Alex P. Michael
AEAhmad Elkouzi
Ahmad Elkouzi
RERodger J. Elble
Rodger J. Elble

1 March 2021 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
MWMatthew W. Weber
Matthew W. Weber
JNJeffrey Z. Nie
Jeffrey Z. Nie
JEJose A. Espinosa
Jose A. Espinosa
KDKristin Delfino
Kristin Delfino
AMAlex P. Michael
Alex P. Michael